Vanda Atypical Antipsychotic Shows Apparent Genetic Response In Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
Study of iloperidone in schizophrenics meets its primary endpoint and also included a genetic profiling evaluation.